Without The Digitisation Process News Today

So here, for example, i can see that the ai risk is low — its a low—risk patient. some cancer experts see real promise in al tools like owkins, but there are still challenges. its really exciting - work and its showing where the future lies for pathology. while it might not be absolutely. there yet for clinical deployment, i think its a really important first step, and something. that we should be encouraged by. the real benefit to patients of these is patient safety . in the first instance ...